Newsroom

Sorted by: Latest

-

First Brands Group Commences Wind Down of North American Brake Parts Inc., Cardone, and Autolite Business Units

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--First Brands Group, LLC (“First Brands” or the “Company”), a leading global supplier of automotive parts, announced that it has commenced a wind down of certain of its North American business operations, including its Brake Parts Inc., Cardone, and Autolite brands. First Brands’ remaining business units continue to operate while the Company assesses pathways to transition these operations to new ownership. “Over the past several months, we explored all a...
-

Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 1/23/2026 Issue ¦ QNB Finance Ltd - Series 450 USD 20,000,000 FRN due January 2028     ISIN Number ¦ XS2580670375 ISIN Reference ¦ 258067037 Issue Nomin USD ¦ 20000000 Period ¦ 10/31/2025 to 1/30/2026   Payment Date 1/30/2026 Number of Days ¦ 91 Rate ¦ 5.26036   Denomination USD ¦ 200000   ¦ 20000000   ¦       Amount Payable per Denomination ¦ 2659.4   ¦ 265940.42   ¦       Bank of New York     Rate...
-

Samuel Merritt University and Oakland Roots SC Launch First-of-Its-Kind Integrated Biomechanics Performance Assessment for Professional Athletes

OAKLAND, Calif.--(BUSINESS WIRE)--Samuel Merritt University (SMU) today announced a new partnership with Oakland Roots SC to assess players’ movement and performance for the club’s full professional roster at SMU’s Motion Analysis Research Center (MARC). The initiative brings all Oakland Roots players to SMU’s state-of-the-art MARC facility for a two-hour, multi-station assessment designed to establish individualized performance baselines, identify movement patterns and support long-term athlet...
-

IQM Quantum Computers nombra a Jan Goetz como único CEO para liderar la próxima fase de crecimiento global

ESPOO, Finlandia--(BUSINESS WIRE)--IQM Quantum Computers, líder mundial en computadoras cuánticas superconductoras de pila completa, anunció hoy una transición de su estructura de co-CEO a un modelo de CEO único. El cofundador y actual co-CEO Dr. Jan Goetz se convertirá en el único CEO a partir del 1 de enero, tras una resolución aprobada por la junta directiva de IQM. Además, el Dr. Søren Hein fue nombrado director de operaciones y CEO adjunto. Como parte de la transición, Mikko Välimäki dejar...
-

IQM Quantum Computers designa Jan Goetz como Diretor Executivo único para liderar próxima fase de crescimento mundial

ESPOO, Finlândia--(BUSINESS WIRE)--A IQM Quantum Computers, líder mundial em computadores quânticos supercondutores de sequenciamento completo, anunciou hoje a transição de sua estrutura com co-diretor executivo para um modelo com um único diretor executivo. O cofundador e atual co-diretor executivo, Dr. Jan Goetz, se torna o único diretor executivo a partir de 1o de janeiro, seguindo uma resolução aprovada pelo conselho da IQM, com o Dr. Søren Hein sendo designado Diretor de Operações e Vice-D...
-

IQMクアンタム・コンピューターズ、ヤン・ゲーツを単独CEOに任命 次のグローバル成長段階を主導

フィンランド、エスポー--(BUSINESS WIRE)--(ビジネスワイヤ) -- フルスタック型の超伝導量子コンピューター分野で世界をリードするIQMクアンタム・コンピューターズは、共同CEO体制から単独CEO体制へ移行すると発表しました。 IQMの共同創業者であり現共同CEOのヤン・ゲーツ博士は、IQM取締役会の決議を受け、2026年1月1日付で単独CEOに就任しました。 あわせて、ソーレン・ハイン博士が最高執行責任者(COO)兼副CEOに任命されました。 この移行の一環として、ミッコ・ヴァリマキは共同CEOとして成功を収めた後、商業部門における役割を退任します。同氏は、事業の継続性と円滑な移行を確保するため、2026年3月31日までアドバイザーとして同社を支援します。 IQM取締役会会長のジーク・ペッティング博士は次のように述べています。「過去2年間にわたり、共同CEO体制はIQMにとって非常に有効でした。ミッコ・ヴァリマキの多大な貢献に感謝します。単独CEO体制への移行は、組織としての成熟を反映するものであり、持続可能なグローバル展開と長期的成長の次の段階を実現するための体...
-

Aelis Farma Announces Its 2026 Financial Calendar

BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS, PEA-PME eligible), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain and peripheral diseases involving the CB1 receptor, today announces its indicative financial calendar for the financial year 2026.  Event  Date of release*  2025 Annual Results  Monday, March 30, 2026  Annual General Meeting  Wednesday, June 3, 2026  2026 Half-Year Results  Tuesd...
-

PROLLENIUM® Names Erick Brenner as Chief Executive Officer

RICHMOND HILL, Ontario--(BUSINESS WIRE)--PROLLENIUM® Medical Technologies, a privately held medical aesthetics company, has appointed Erick Brenner as Chief Executive Officer, effective immediately. Brenner succeeds Walter Geiger, who has served as Interim CEO since April 2025, and will return to his role as Operating Partner at ARCHIMED, PROLLENIUM®’s majority shareholder. Brenner most recently served as President of Galderma U.S., where he oversaw a $1.8 billion portfolio across injectable ae...
-

Primeˣ 260 and Slimˣ 260 Set a New Standard for Long-Range, Ultra-Precise Motion Capture with 26 MP Resolution and ±0.050 mm 3D Accuracy

CORVALLIS, Ore.--(BUSINESS WIRE)--OptiTrack, a worldwide leader in 3D optical tracking systems, today announced the 260 X-Series camera family, built to deliver OptiTrack’s highest-accuracy tracking in demanding, large-volume environments. Primeˣ and Slimˣ 260 brings together ±0.050 mm 3D accuracy (50 microns) and a 26 Megapixel sensor to deliver exceptionally stable tracking across massive capture spaces, up to 40m passive range and 91m active tracking range. Higher pixel density improves trac...
-

Aelis Farma annonce son calendrier financier pour l’exercice 2026

BORDEAUX, France--(BUSINESS WIRE)--Regulatory News : Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements des maladies cérébrales et périphériques impliquant le récepteur CB1, annonce aujourd’hui son calendrier financier indicatif pour l’exercice 2026.  Évènement  Date de publication*  Résultats annuels 2025  Le lundi 30 mars 2026  Assemblée générale annuelle  Le mercredi 3 juin 202...